How To Deal With Uveitis Patients?

Author(s): P. Yang* , L. Du , Z. Ye .

Journal Name: Current Molecular Medicine

Volume 17 , Issue 7 , 2017

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer

Abstract:

During the past nine years, our center has grown into the largest uveitis referral center in China. To deal with this increasing stream of patients we have developed a management system to coordinate communication with our patients, their referring ophthalmologists, consultations with other medical specialties and worldrenowned foreign uveitis specialists. We have established the biggest database of uveitis patients records allowing continuous analysis of clinical features and response to treatment of patients with various uveitis entities as well as the evaluation of the relevance of various ancillary tests performed in this patient group. The establishment of a specimen biobank has been shown to be instrumental in the research on the complex immunopathological mechanisms involved in this disease. The close interaction between patient care and clinical research under one roof has led to a novel understanding of disease mechanisms and will undoubtedly lead to a tailored treatment for this disease.

Keywords: Uveitis, inflammation, blindness, specimen biobank, immunopathological mechanisms, Behcet's disease, Vogt-Koyanagi-Harada disease, Fuchs syndrome.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 17
ISSUE: 7
Year: 2017
Page: [468 - 470]
Pages: 3
DOI: 10.2174/1566524018666180207153342
Price: $58

Article Metrics

PDF: 19
HTML: 3